The antitrust agency paused its lawsuit against the pharmacy benefit manager while the two discuss a proposed consent ...

Grocery chain Albertsons, which offers pharmacies, is suing the Cigna-owned pharmacy benefit manager Express Scripts for at ...

The Federal Trade Commission (FTC) and Evernorth may be on the cusp of a settlement to resolve allegations that the company's ...

Cigna signed a definitive agreement to acquire Express Scripts for $67 billion in cash and stock, including assumption of $15 billion in Express Scripts debt. Here are five things to know about the ...

“Together with Express Scripts, Cigna will further accelerate our strategy of Go Deeper, Go Local and Go Beyond by improving affordability and choice, expanding our distribution reach, and further ...

A pharmacist retrieves a a medication. (Joe Raedle/Getty Images.) The owner of one of the three largest pharmacy middlemen in the United States last week filed suit to quash an attempt by the Federal ...

Cigna subsidiary Express Scripts Inc. claimed the Federal Trade Commission's July interim report—which claims middlemen have driven up prescription drug costs and exacerbated independent pharmacies—is ...

The state of Arkansas is suing Optum, OptumRx and parent company UnitedHealth Group, Cigna's Evernorth and its pharmacy benefit manager Express Scripts, and others over the opioid epidemic. The ...

The original version of this story was published on Law.com Cigna subsidiary Express Scripts Inc. sued the Federal Trade Commission for defamation Tuesday, claiming FTC’s report that pharmacy benefit ...

Cigna Corp. agreed to buy Express Scripts Holding in an about $54 billion deal that builds on the rapid transformation of the health-care business as companies and consumers chafe at rising costs. The ...

Dec. 19--New Jersey regulators have approved the $67 billion acquisition of Express Scripts Holding Co. by Cigna Corp., the last state to give the green light to the deal, the Bloomfield health ...

Cigna's pharmacy benefit manager Express Scripts has filed a lawsuit against the FTC over the agency's recent report on PBMs, which highlighted their contribution to soaring drug prices in the U.S.